pharmaceutical-patents
2 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 23A344 | Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc., et al. | Federal Circuit | 2023-10-17 | Presumed Complete | KSR-standard obviousness patent-law pharmaceutical-patents predictable-result prior-art | Whether the Federal Circuit's obviousness analysis complies with the Supreme Court's standard in KSR International Co. v. Teleflex Inc. by requiring t… | |
| 18-182 | AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc., et al. | Federal Circuit | 2018-08-09 | Denied | Response Waived | actual-controversy article-iii declaratory-judgment drug-exclusivity fda-approval generic-drugs patent-invalidity pharmaceutical pharmaceutical-patents standing | Whether the 'actual controversy' requirement of the Declaratory Judgment Act requires a party seeking to introduce a generic drug product to file an a… |